Stearns and Poletti present a technically impressive study that aims to uncover a deeper understanding of microsaccade function: their role in perceptual modulation and the associated temporal ...
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results